PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia · Delayed Price · Currency is IDR 238.00
-6.00 (-2.46%)
At close: Sep 22, 2026
IDX:OBAT Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 166,012 | 232,800 | - | - | - | - | |
Market Cap Growth | -40.37% | - | - | - | - | - |
Enterprise Value | 132,454 | 202,347 | - | - | - | - |
Last Close Price | 244.00 | 377.31 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.84 | 10.28 | - | - | - | - |
PS Ratio | 0.96 | 1.45 | - | - | - | - |
PB Ratio | 1.17 | 2.12 | - | - | - | - |
P/TBV Ratio | 1.22 | 2.19 | - | - | - | - |
P/FCF Ratio | - | 72.67 | - | - | - | - |
P/OCF Ratio | 13.80 | 9.81 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.77 | 1.26 | - | - | - | - |
EV/EBITDA Ratio | 5.09 | 6.17 | - | - | - | - |
EV/EBIT Ratio | 5.33 | 6.21 | - | - | - | - |
EV/FCF Ratio | - | 63.16 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.22 | 0.09 | 0.03 | 0.01 |
Debt / EBITDA Ratio | 0.38 | 0.23 | 0.24 | 0.11 | 0.03 | 0.01 |
Debt / FCF Ratio | - | 2.32 | 1.50 | 0.27 | 0.05 | 0.01 |
Net Debt / Equity Ratio | -0.27 | -0.32 | 0.05 | -0.11 | -0.04 | -0.10 |
Net Debt / EBITDA Ratio | -1.52 | -1.07 | 0.06 | -0.13 | -0.04 | -0.09 |
Net Debt / FCF Ratio | 2.77 | -10.99 | 0.37 | -0.34 | -0.08 | -0.12 |
Asset Turnover | 1.15 | 1.63 | 2.36 | 1.84 | 1.53 | - |
Inventory Turnover | 3.97 | 4.61 | 4.57 | 5.29 | 4.53 | - |
Quick Ratio | 4.30 | 4.39 | 0.97 | 0.45 | 0.16 | 0.42 |
Current Ratio | 6.60 | 6.65 | 3.07 | 0.99 | 0.67 | 0.98 |
Return on Equity (ROE) | 12.73% | 33.29% | 96.77% | 68.60% | 69.06% | - |
Return on Assets (ROA) | 10.14% | 20.67% | 46.21% | 29.27% | 33.73% | - |
Return on Invested Capital (ROIC) | 15.62% | 41.97% | 92.31% | 71.73% | 67.71% | 87.05% |
Return on Capital Employed (ROCE) | 16.20% | 27.10% | 69.40% | 67.60% | 86.70% | 97.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.33% | 9.73% | - | - | - | - |
FCF Yield | -8.37% | 1.38% | - | - | - | - |
Payout Ratio | 42.22% | 59.29% | 85.13% | 65.56% | 121.12% | 51.12% |
Buyback Yield / Dilution | 4.24% | - | -39.53% | 7.13% | - | - |
Total Shareholder Return | 13.40% | - | -39.53% | 7.13% | - | - |